(Q54599986)

1 June 2018

title

The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. (English)

1 reference

1 June 2018

0 references

4

1 reference

1 June 2018

author name string

P K Aggarwal

series ordinal

1

1 reference

1 June 2018

N Chandel

series ordinal

2

1 reference

1 June 2018

V Jain

series ordinal

3

1 reference

1 June 2018

publication date

31 March 2011

1 reference

1 June 2018

Journal of Human Hypertension

published in

1 reference

1 June 2018

volume

26

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

236-241

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/jhh.2011.29

exact match

0 references

cites work

Mechanisms of disease: Pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Endothelin, elastase, and endothelial dysfunction in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.29

7 January 2021

Identifiers

DOI

10.1038/JHH.2011.29

1 reference

1 June 2018

1 reference

1 June 2018